Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer
- PMID: 28674681
- PMCID: PMC5474682
- DOI: 10.3389/fped.2017.00121
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer
Abstract
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex disease that affects children and adolescents as well as adults. The etiology has not been established. While many pediatricians and other health-care providers are aware of ME/CFS, they often lack essential knowledge that is necessary for diagnosis and treatment. Many young patients experience symptoms for years before receiving a diagnosis. This primer, written by the International Writing Group for Pediatric ME/CFS, provides information necessary to understand, diagnose, and manage the symptoms of ME/CFS in children and adolescents. ME/CFS is characterized by overwhelming fatigue with a substantial loss of physical and mental stamina. Cardinal features are malaise and a worsening of symptoms following minimal physical or mental exertion. These post-exertional symptoms can persist for hours, days, or weeks and are not relieved by rest or sleep. Other symptoms include cognitive problems, unrefreshing or disturbed sleep, generalized or localized pain, lightheadedness, and additional symptoms in multiple organ systems. While some young patients can attend school, on a full or part-time basis, many others are wheelchair dependent, housebound, or bedbound. Prevalence estimates for pediatric ME/CFS vary from 0.1 to 0.5%. Because there is no diagnostic test for ME/CFS, diagnosis is purely clinical, based on the history and the exclusion of other fatiguing illnesses by physical examination and medical testing. Co-existing medical conditions including orthostatic intolerance (OI) are common. Successful management is based on determining the optimum balance of rest and activity to help prevent post-exertional symptom worsening. Medications are helpful to treat pain, insomnia, OI and other symptoms. The published literature on ME/CFS and specifically that describing the diagnosis and management of pediatric ME/CFS is very limited. Where published studies are lacking, recommendations are based on the clinical observations and practices of the authors.
Keywords: adolescent; chronic fatigue syndrome; diagnosis; joint hypermobility; management; myalgic encephalomyelitis; pediatric; postural tachycardia syndrome.
Figures

Similar articles
-
Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.Rev Environ Health. 2015;30(4):223-49. doi: 10.1515/reveh-2015-0026. Rev Environ Health. 2015. PMID: 26613325 Review.
-
Typing myalgic encephalomyelitis by infection at onset: A DecodeME study.NIHR Open Res. 2023 Aug 21;3:20. doi: 10.3310/nihropenres.13421.4. eCollection 2023. NIHR Open Res. 2023. PMID: 37881452 Free PMC article.
-
Medically Documenting Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Cases.Front Pediatr. 2019 Jul 2;7:231. doi: 10.3389/fped.2019.00231. eCollection 2019. Front Pediatr. 2019. PMID: 31334205 Free PMC article.
-
Cerebral blood flow remains reduced after tilt testing in myalgic encephalomyelitis/chronic fatigue syndrome patients.Clin Neurophysiol Pract. 2021 Sep 23;6:245-255. doi: 10.1016/j.cnp.2021.09.001. eCollection 2021. Clin Neurophysiol Pract. 2021. PMID: 34667909 Free PMC article.
-
[Post-COVID syndrome with fatigue and exercise intolerance: myalgic encephalomyelitis/chronic fatigue syndrome].Inn Med (Heidelb). 2022 Aug;63(8):830-839. doi: 10.1007/s00108-022-01369-x. Epub 2022 Jul 13. Inn Med (Heidelb). 2022. PMID: 35925074 Free PMC article. Review. German.
Cited by
-
Theory: Treatments for Prolonged ICU Patients May Provide New Therapeutic Avenues for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).Front Med (Lausanne). 2021 May 7;8:672370. doi: 10.3389/fmed.2021.672370. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34026797 Free PMC article.
-
Malmö POTS symptom score: Assessing symptom burden in postural orthostatic tachycardia syndrome.J Intern Med. 2023 Jan;293(1):91-99. doi: 10.1111/joim.13566. Epub 2022 Sep 16. J Intern Med. 2023. PMID: 36111700 Free PMC article.
-
Elements of Suffering in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Experience of Loss, Grief, Stigma, and Trauma in the Severely and Very Severely Affected.Healthcare (Basel). 2021 May 9;9(5):553. doi: 10.3390/healthcare9050553. Healthcare (Basel). 2021. PMID: 34065069 Free PMC article. Review.
-
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Efficacy of Repeat Immunoadsorption.J Clin Med. 2020 Jul 30;9(8):2443. doi: 10.3390/jcm9082443. J Clin Med. 2020. PMID: 32751659 Free PMC article.
-
Molecular Hydrogen as a Medical Gas for the Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Possible Efficacy Based on a Literature Review.Front Neurol. 2022 Apr 11;13:841310. doi: 10.3389/fneur.2022.841310. eCollection 2022. Front Neurol. 2022. PMID: 35493814 Free PMC article. Review.
References
-
- Institute of Medicine. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Washington, DC: The National Academies Press; (2015). - PubMed
-
- World Health Organization. International Classification of Diseases (ICD). (2016). Available from: http://apps.who.int/classifications/icd10/browse/2016/en#/G90-G99
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources